Jose Luis Sanchez Menoyo
Overview
Explore the profile of Jose Luis Sanchez Menoyo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mena J, Alloza I, Tulloch Navarro R, Aldekoa A, Diez Garcia J, Villanueva Etxebarria A, et al.
Front Immunol
. 2022 Feb;
12:816930.
PMID: 35111166
Intronic single-nucleotide polymorphisms (SNPs) in the gene are associated with the risk for multiple sclerosis (MS) and rheumatoid arthritis by genome-wide association studies (GWAS). The risk alleles have been linked...
2.
Zhou Y, Claflin S, Stankovich J, van der Mei I, Simpson Jr S, Roxburgh R, et al.
Mult Scler
. 2019 Nov;
26(13):1765-1774.
PMID: 31668127
Background: The Multiple Sclerosis Severity Score (MSSS) is a widely used measure of the disability progression rate. However, the global MSSS may not be the best basis for comparison between...
3.
Nguyen A, Kubala Havrdova E, Horakova D, Izquierdo G, Kalincik T, van der Walt A, et al.
Mult Scler Relat Disord
. 2019 Jan;
28:235-243.
PMID: 30623864
Background: Exposure to disease-modifying therapy (DMT) during early pregnancy in women with relapsing-remitting MS (RRMS) may be increasing. Objective: To retrospectively determine incidence of pregnancy, DMT exposure and pregnancy outcomes...
4.
Fragoso Y, Spelman T, Boz C, Alroughani R, Lugaresi A, Vucic S, et al.
Mult Scler Relat Disord
. 2018 May;
22:166.
PMID: 29807821
No abstract available.
5.
Ruisanchez Nieva A, Sanchez Menoyo J, Escalza Cortina I, Foncea Beti N, Beldarrain M, Garcia-Monco J
Neurol Clin Pract
. 2018 Apr;
7(5):404-406.
PMID: 29620080
No abstract available.
6.
Tao C, Simpson Jr S, van der Mei I, Blizzard L, Havrdova E, Horakova D, et al.
J Neurol Neurosurg Psychiatry
. 2016 Nov;
87(12):1343-1349.
PMID: 27810919
Background: Age at onset (AAO) in multiple sclerosis (MS) is an important marker of disease severity and may have prognostic significance. Understanding what factors can influence AAO may shed light...
7.
Lorscheider J, Buzzard K, Jokubaitis V, Spelman T, Havrdova E, Horakova D, et al.
Brain
. 2016 Jul;
139(Pt 9):2395-405.
PMID: 27401521
A number of studies have been conducted with the onset of secondary progressive multiple sclerosis as an inclusion criterion or an outcome of interest. However, a standardized objective definition of...
8.
Stewart T, Spelman T, Havrdova E, Horakova D, Trojano M, Izquierdo G, et al.
Mult Scler
. 2016 Apr;
23(2):266-276.
PMID: 27055805
Objective: This study evaluated the effect of relapse phenotype on disability accumulation in multiple sclerosis. Methods: Analysis of prospectively collected data was conducted in 19,504 patients with relapse-onset multiple sclerosis...
9.
Fernandez-Vega I, Ruiz-Ojeda J, Juste R, Geijo M, Zarranz J, Sanchez Menoyo J, et al.
Neuropathology
. 2014 Sep;
35(1):56-63.
PMID: 25186620
We report hereby an autopsy case of sporadic mixed phenotype CJD without hereditary burden and a long-term clinical course. An 80-year old man was diagnosed with mild cognitive impairment 27...
10.
Kortazar Zubizarreta I, Sanchez Menoyo J, Ruiz Ojeda J, Olabarria I, Carra J
J Neuroimaging
. 2013 Jan;
24(4):432-3.
PMID: 23317335
No abstract available.